And then I hope we don't hear another peep about a bankruptcy.
I also hope we don't give up 40% of our stock to a combined business we could form with Baudax. I just don't see enough value there for them to end up with 22% of our stock (with us holding the other 18% as part of the combined business). But, that value COULD be there, when TeraImmune is considered. I just don't know. I also don't know how they were trading in the $30 range in the last year.
For that matter, a merger with Baudax could even be bigger than just as part of a combined business, assuming we aren't just looking for a partnership, which I initially thought. I'll be glad to see the 10-Q, and maybe get some guidance.